KEQU
Kewaunee Scientific Corporation
33.80$
-0.1%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3.8% | +6.7% | -2.0% | +1.9% | +40.7% | +2.9% | -0.6% | -2.3% | -6.9% | +1.3% | -1.4% | |
| – | +5.8% | +0.7% | -4.3% | +4.0% | +12.6% | +9.0% | -1.0% | -3.0% | -8.9% | +1.8% | -1.4% | |
| – | +97.6% | -4.3% | -6.7% | +7.2% | -63.6% | +58.0% | +30.4% | -29.8% | -24.4% | +12.3% | -29.0% | |
| – | +97.6% | -4.3% | -6.7% | +7.2% | -63.6% | +58.0% | +30.4% | -29.8% | -24.4% | +12.3% | -29.0% | |
| – | -3.5% | -112.5% | – | -3.8% | +37.1% | +8.6% | -8.8% | +3.7% | -8.3% | +8.5% | -0.9% | |
| – | +0.8% | -5.3% | -6.7% | -3.2% | +69.1% | +4.1% | +6.3% | +1.6% | -7.3% | -7.2% | -2.4% | |
| – | – | – | – | – | – | -11.8% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | – | – | – | – | – | -2.1% | -2.2% | -2.2% | -2.3% | -2.3% | -2.4% | |
| – | +3.4% | -3.0% | -5.2% | -0.9% | +72.1% | +1.1% | -3.0% | -5.8% | -11.9% | -1.9% | -2.9% | |
| – | +8.8% | -3.2% | -10.0% | -0.6% | +37.6% | +7.1% | -6.0% | -9.3% | +6.5% | -0.9% | -2.3% | |
| – | -31.2% | -11.8% | +8.2% | -47.6% | +267.6% | -34.7% | -48.8% | +101.0% | +29.7% | -9.0% | +20.0% | |
| – | -0.5% | +21.9% | -11.4% | +4.1% | +14.3% | +10.2% | -2.6% | -13.9% | +4.3% | -5.0% | -4.0% | |
| – | – | – | – | – | – | -2.9% | -0.7% | -6.1% | -49.3% | -7.6% | -8.3% | |
| – | +4.7% | +24.2% | +2.3% | +5.9% | +2.5% | +6.0% | +4.1% | +4.1% | +1.2% | +5.7% | +0.4% | |
| – | +7.4% | +30.2% | +4.6% | +6.1% | +2.6% | +9.0% | +5.2% | +3.9% | +1.1% | +5.2% | +2.5% | |
| – | +1.2% | +0.2% | -0.2% | +0.2% | +0.7% | -0.5% | -0.6% | +0.5% | +0.2% | +0.4% | -2.5% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.